Plain-English translation of NCT06998407 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This trial is testing a new medication called , which is designed to slow the growth of a specific type of advanced breast cancer. Researchers want to understand how safe the medication is, how the body processes it, and whether it works better when given by itself or combined with other cancer treatments.
Some patients with advanced hormone-sensitive breast cancer need better treatment options. This trial is exploring whether this new medication — either alone or paired with existing cancer drugs — can help patients whose cancer has progressed or spread.
You likely qualify if…
You likely don't qualify if…
You would visit a research clinic regularly over several months to take this medication by mouth twice daily in 28-day cycles. Depending on which part of the study you join, you may take the medication alone or combined with one or two other cancer drugs. Throughout your participation, you'll have blood tests, imaging scans, and check-ins with the research team to monitor how well the treatment works and any side effects you experience.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States